Biochemical Engineering
Thermo Fisher Considers Buying $8 Billion Diagnostics Firm Qiagen
13th November 2019
Thermo Fisher has approached the Dutch company about a potential purchase that could become one of its biggest-ever acquisitions, reports said, asking not to be identified because the information is private. Shares of Qiagen rose 13% to 33.20 euros at 13:10 in Frankfurt, giving it a market value of $8.3 billion. Source: Bloomberg 13/11/2019
Back to group news